Gohar Azhar
Concepts (267)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amino Acids, Essential | 6 | 2024 | 136 | 1.910 |
Why?
| | Delirium | 2 | 2023 | 50 | 1.520 |
Why?
| | Health Literacy | 2 | 2023 | 131 | 1.370 |
Why?
| | Serum Response Factor | 11 | 2025 | 45 | 1.300 |
Why?
| | Dietary Supplements | 6 | 2024 | 470 | 1.130 |
Why?
| | MicroRNAs | 4 | 2025 | 392 | 0.920 |
Why?
| | Alzheimer Disease | 3 | 2025 | 356 | 0.800 |
Why?
| | Lewy Body Disease | 1 | 2023 | 10 | 0.800 |
Why?
| | Dietary Proteins | 7 | 2021 | 247 | 0.760 |
Why?
| | Aged | 18 | 2025 | 10242 | 0.660 |
Why?
| | Lipopolysaccharides | 3 | 2025 | 205 | 0.580 |
Why?
| | Eating | 3 | 2024 | 158 | 0.550 |
Why?
| | Transcription Factors | 8 | 2024 | 570 | 0.550 |
Why?
| | Heart Failure | 6 | 2025 | 527 | 0.540 |
Why?
| | Protein Biosynthesis | 4 | 2020 | 267 | 0.490 |
Why?
| | Porphyromonas gingivalis | 3 | 2025 | 17 | 0.490 |
Why?
| | Myocardium | 11 | 2024 | 471 | 0.480 |
Why?
| | Cardiovascular Diseases | 1 | 2021 | 493 | 0.480 |
Why?
| | Humans | 39 | 2025 | 52441 | 0.450 |
Why?
| | Gastroscopy | 1 | 2014 | 21 | 0.440 |
Why?
| | Meals | 4 | 2020 | 58 | 0.440 |
Why?
| | Gastrostomy | 1 | 2014 | 55 | 0.430 |
Why?
| | Doxorubicin | 2 | 2024 | 246 | 0.380 |
Why?
| | Heart | 4 | 2015 | 352 | 0.370 |
Why?
| | Quality Improvement | 2 | 2023 | 226 | 0.340 |
Why?
| | Alternative Splicing | 3 | 2025 | 61 | 0.330 |
Why?
| | Algorithms | 1 | 2014 | 673 | 0.330 |
Why?
| | Caregivers | 2 | 2023 | 239 | 0.330 |
Why?
| | Gene Expression Profiling | 4 | 2025 | 1099 | 0.310 |
Why?
| | Accidental Falls | 2 | 2024 | 107 | 0.290 |
Why?
| | Anabolic Agents | 2 | 2019 | 41 | 0.280 |
Why?
| | Gene Expression Regulation | 10 | 2025 | 1004 | 0.280 |
Why?
| | Aging | 5 | 2016 | 722 | 0.280 |
Why?
| | Mice | 15 | 2025 | 5899 | 0.260 |
Why?
| | Ventricular Pressure | 1 | 2006 | 16 | 0.260 |
Why?
| | Isoproterenol | 1 | 2006 | 56 | 0.260 |
Why?
| | Mitochondria | 7 | 2025 | 420 | 0.250 |
Why?
| | Oxygen Consumption | 2 | 2019 | 193 | 0.250 |
Why?
| | Female | 16 | 2025 | 28277 | 0.240 |
Why?
| | Microglia | 2 | 2025 | 139 | 0.240 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2006 | 22 | 0.240 |
Why?
| | Cachexia | 1 | 2006 | 28 | 0.240 |
Why?
| | Musculoskeletal Pain | 1 | 2025 | 10 | 0.240 |
Why?
| | Male | 14 | 2025 | 26874 | 0.240 |
Why?
| | Aged, 80 and over | 5 | 2024 | 3449 | 0.230 |
Why?
| | STAT3 Transcription Factor | 1 | 2025 | 89 | 0.230 |
Why?
| | Caspases, Initiator | 1 | 2025 | 12 | 0.230 |
Why?
| | Micronesia | 1 | 2025 | 111 | 0.230 |
Why?
| | Transcriptome | 2 | 2025 | 357 | 0.220 |
Why?
| | Neuralgia | 1 | 2025 | 68 | 0.220 |
Why?
| | Inflammasomes | 1 | 2025 | 64 | 0.220 |
Why?
| | Anthracyclines | 1 | 2024 | 34 | 0.220 |
Why?
| | Interleukin-18 | 1 | 2024 | 26 | 0.210 |
Why?
| | Paraffin Embedding | 1 | 2024 | 52 | 0.210 |
Why?
| | Formaldehyde | 1 | 2024 | 51 | 0.210 |
Why?
| | Body Composition | 4 | 2021 | 343 | 0.210 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2024 | 114 | 0.210 |
Why?
| | Valine | 1 | 2024 | 57 | 0.210 |
Why?
| | Sequence Analysis, RNA | 1 | 2024 | 96 | 0.200 |
Why?
| | Animals | 18 | 2025 | 13485 | 0.200 |
Why?
| | Neutrophils | 1 | 2024 | 148 | 0.200 |
Why?
| | Amino Acids, Branched-Chain | 1 | 2024 | 43 | 0.200 |
Why?
| | Analgesics | 1 | 2024 | 106 | 0.200 |
Why?
| | Oxidative Stress | 4 | 2025 | 805 | 0.200 |
Why?
| | Actins | 2 | 2022 | 112 | 0.200 |
Why?
| | Chronic Disease | 1 | 2025 | 579 | 0.200 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2023 | 50 | 0.200 |
Why?
| | Heart Diseases | 1 | 2025 | 217 | 0.190 |
Why?
| | Chronic Pain | 1 | 2025 | 189 | 0.190 |
Why?
| | Nitric Oxide | 2 | 2015 | 238 | 0.190 |
Why?
| | Blood Proteins | 1 | 2023 | 84 | 0.190 |
Why?
| | Cell Line | 5 | 2025 | 1020 | 0.190 |
Why?
| | Double-Blind Method | 2 | 2021 | 726 | 0.190 |
Why?
| | Ambulatory Care Facilities | 1 | 2023 | 122 | 0.190 |
Why?
| | Dopamine | 1 | 2023 | 170 | 0.190 |
Why?
| | Adult | 10 | 2025 | 14205 | 0.180 |
Why?
| | Diabetes Mellitus | 1 | 2025 | 318 | 0.180 |
Why?
| | Proteomics | 1 | 2024 | 332 | 0.180 |
Why?
| | Food Analysis | 1 | 2021 | 28 | 0.170 |
Why?
| | Positron-Emission Tomography | 1 | 2023 | 297 | 0.170 |
Why?
| | Arkansas | 2 | 2025 | 2013 | 0.170 |
Why?
| | Sirtuins | 1 | 2021 | 12 | 0.170 |
Why?
| | Actinidia | 1 | 2020 | 8 | 0.170 |
Why?
| | Geriatric Assessment | 1 | 2021 | 109 | 0.170 |
Why?
| | Digestion | 1 | 2020 | 29 | 0.170 |
Why?
| | Postprandial Period | 1 | 2020 | 75 | 0.160 |
Why?
| | Genetic Variation | 1 | 2021 | 226 | 0.160 |
Why?
| | Muscle Proteins | 2 | 2020 | 343 | 0.160 |
Why?
| | Blood Glucose | 3 | 2019 | 483 | 0.150 |
Why?
| | Blood Cells | 1 | 2019 | 37 | 0.150 |
Why?
| | Food, Formulated | 1 | 2019 | 41 | 0.150 |
Why?
| | Mitochondria, Muscle | 1 | 2019 | 40 | 0.150 |
Why?
| | Histones | 2 | 2022 | 315 | 0.150 |
Why?
| | Up-Regulation | 3 | 2015 | 462 | 0.150 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2019 | 63 | 0.150 |
Why?
| | Analgesics, Opioid | 1 | 2024 | 601 | 0.140 |
Why?
| | Sirtuin 2 | 1 | 2017 | 15 | 0.140 |
Why?
| | Breakfast | 1 | 2017 | 19 | 0.140 |
Why?
| | Human Growth Hormone | 1 | 2017 | 49 | 0.130 |
Why?
| | Middle Aged | 5 | 2025 | 13133 | 0.130 |
Why?
| | RNA, Messenger | 5 | 2021 | 1134 | 0.130 |
Why?
| | Diet | 1 | 2021 | 591 | 0.130 |
Why?
| | Mitochondria, Heart | 1 | 2016 | 39 | 0.120 |
Why?
| | Muscle Strength | 1 | 2017 | 132 | 0.120 |
Why?
| | Elder Nutritional Physiological Phenomena | 1 | 2015 | 7 | 0.120 |
Why?
| | Cross-Over Studies | 3 | 2020 | 236 | 0.120 |
Why?
| | Breast Neoplasms | 1 | 2024 | 1203 | 0.120 |
Why?
| | Signal Transduction | 4 | 2025 | 1724 | 0.120 |
Why?
| | Protein Isoforms | 3 | 2025 | 127 | 0.120 |
Why?
| | Feeding Behavior | 1 | 2017 | 189 | 0.120 |
Why?
| | Cardiovascular Agents | 1 | 2015 | 65 | 0.110 |
Why?
| | Citrulline | 1 | 2015 | 98 | 0.110 |
Why?
| | Mice, Transgenic | 4 | 2014 | 566 | 0.110 |
Why?
| | Intubation, Gastrointestinal | 1 | 2014 | 24 | 0.110 |
Why?
| | Age Factors | 3 | 2024 | 1120 | 0.110 |
Why?
| | Metformin | 1 | 2015 | 82 | 0.110 |
Why?
| | Health Surveys | 1 | 2014 | 238 | 0.100 |
Why?
| | Residence Characteristics | 1 | 2014 | 159 | 0.100 |
Why?
| | Acute Disease | 1 | 2014 | 384 | 0.100 |
Why?
| | Hypoglycemic Agents | 1 | 2015 | 223 | 0.100 |
Why?
| | beta-Galactosidase | 1 | 2013 | 32 | 0.100 |
Why?
| | Exons | 2 | 2025 | 101 | 0.100 |
Why?
| | Insulin | 3 | 2021 | 485 | 0.100 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2013 | 83 | 0.100 |
Why?
| | Cognition | 1 | 2014 | 363 | 0.090 |
Why?
| | Glucose | 1 | 2013 | 356 | 0.090 |
Why?
| | Cardiomegaly | 1 | 2011 | 55 | 0.080 |
Why?
| | Longevity | 1 | 2010 | 86 | 0.080 |
Why?
| | Protein Binding | 3 | 2025 | 673 | 0.080 |
Why?
| | Time Factors | 2 | 2014 | 2987 | 0.080 |
Why?
| | Egg Proteins | 2 | 2021 | 18 | 0.080 |
Why?
| | Lysine | 2 | 2022 | 90 | 0.080 |
Why?
| | Amino Acid Sequence | 5 | 2011 | 576 | 0.080 |
Why?
| | Collagen | 1 | 2010 | 215 | 0.080 |
Why?
| | Young Adult | 4 | 2021 | 4346 | 0.070 |
Why?
| | Blotting, Western | 2 | 2006 | 587 | 0.070 |
Why?
| | NADH Dehydrogenase | 1 | 2008 | 9 | 0.070 |
Why?
| | Electron Transport Complex I | 1 | 2008 | 22 | 0.070 |
Why?
| | Promoter Regions, Genetic | 4 | 2017 | 465 | 0.070 |
Why?
| | Protein Structure, Tertiary | 2 | 2021 | 260 | 0.070 |
Why?
| | Kinetics | 2 | 2020 | 613 | 0.060 |
Why?
| | Trans-Activators | 3 | 2016 | 137 | 0.060 |
Why?
| | Rats | 3 | 2024 | 3228 | 0.060 |
Why?
| | Drug Repositioning | 1 | 2025 | 15 | 0.060 |
Why?
| | Nuclear Proteins | 3 | 2016 | 247 | 0.060 |
Why?
| | Nitriles | 1 | 2025 | 51 | 0.060 |
Why?
| | RNA Splicing | 1 | 2025 | 43 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 580 | 0.060 |
Why?
| | Molecular Docking Simulation | 1 | 2025 | 93 | 0.060 |
Why?
| | Molecular Sequence Data | 4 | 2008 | 778 | 0.060 |
Why?
| | Arginine | 2 | 2017 | 183 | 0.060 |
Why?
| | Body Mass Index | 2 | 2019 | 701 | 0.060 |
Why?
| | Amyloid beta-Peptides | 1 | 2025 | 73 | 0.060 |
Why?
| | Cells, Cultured | 3 | 2015 | 1583 | 0.060 |
Why?
| | GPI-Linked Proteins | 1 | 2024 | 32 | 0.050 |
Why?
| | Interleukin-1beta | 1 | 2025 | 84 | 0.050 |
Why?
| | Pyrazoles | 1 | 2025 | 116 | 0.050 |
Why?
| | Pyrimidines | 1 | 2025 | 199 | 0.050 |
Why?
| | Cell Adhesion Molecules | 1 | 2024 | 89 | 0.050 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2024 | 88 | 0.050 |
Why?
| | Tissue Fixation | 1 | 2024 | 35 | 0.050 |
Why?
| | Human Umbilical Vein Endothelial Cells | 2 | 2016 | 102 | 0.050 |
Why?
| | Phosphorylation | 1 | 2025 | 536 | 0.050 |
Why?
| | Isoleucine | 1 | 2024 | 26 | 0.050 |
Why?
| | Antigens, CD | 1 | 2024 | 213 | 0.050 |
Why?
| | Proteins | 1 | 2006 | 353 | 0.050 |
Why?
| | Leucine | 1 | 2024 | 116 | 0.050 |
Why?
| | Reactive Oxygen Species | 1 | 2025 | 415 | 0.050 |
Why?
| | Drug Therapy, Combination | 1 | 2024 | 404 | 0.050 |
Why?
| | Ternary Complex Factors | 1 | 2022 | 4 | 0.050 |
Why?
| | Cell Size | 2 | 2014 | 45 | 0.050 |
Why?
| | Anilides | 1 | 2022 | 20 | 0.050 |
Why?
| | Benzamides | 1 | 2022 | 52 | 0.050 |
Why?
| | Base Sequence | 2 | 2017 | 632 | 0.050 |
Why?
| | NIH 3T3 Cells | 3 | 2008 | 52 | 0.050 |
Why?
| | Muscle, Skeletal | 2 | 2019 | 799 | 0.050 |
Why?
| | Neurons | 1 | 2025 | 442 | 0.050 |
Why?
| | Sex Factors | 1 | 2024 | 735 | 0.050 |
Why?
| | Disease Models, Animal | 1 | 2006 | 1483 | 0.040 |
Why?
| | Risk Factors | 2 | 2024 | 3971 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2022 | 234 | 0.040 |
Why?
| | Meat | 1 | 2021 | 55 | 0.040 |
Why?
| | Cytokines | 1 | 2024 | 622 | 0.040 |
Why?
| | Case-Control Studies | 1 | 2024 | 1202 | 0.040 |
Why?
| | Genetic Loci | 1 | 2021 | 46 | 0.040 |
Why?
| | Plant Proteins | 1 | 2021 | 68 | 0.040 |
Why?
| | Genome | 1 | 2021 | 61 | 0.040 |
Why?
| | Basal Metabolism | 1 | 2020 | 32 | 0.040 |
Why?
| | Animals, Newborn | 2 | 2014 | 355 | 0.040 |
Why?
| | Fasting | 1 | 2020 | 75 | 0.040 |
Why?
| | Zinc | 1 | 2021 | 57 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 1 | 2024 | 1558 | 0.040 |
Why?
| | Proteolysis | 1 | 2020 | 100 | 0.040 |
Why?
| | Absorptiometry, Photon | 1 | 2020 | 161 | 0.040 |
Why?
| | Cell Line, Tumor | 1 | 2024 | 1429 | 0.040 |
Why?
| | Oxidative Phosphorylation Coupling Factors | 1 | 2019 | 6 | 0.040 |
Why?
| | Fruit | 1 | 2020 | 130 | 0.040 |
Why?
| | Beverages | 1 | 2019 | 58 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2016 | 1888 | 0.040 |
Why?
| | Conserved Sequence | 2 | 2011 | 55 | 0.040 |
Why?
| | Monocytes | 1 | 2019 | 124 | 0.040 |
Why?
| | Triglycerides | 1 | 2019 | 171 | 0.040 |
Why?
| | Blood | 1 | 2017 | 24 | 0.030 |
Why?
| | Culture Media | 1 | 2017 | 96 | 0.030 |
Why?
| | Tyrosine | 1 | 2017 | 97 | 0.030 |
Why?
| | Isotope Labeling | 1 | 2017 | 59 | 0.030 |
Why?
| | Blood Platelets | 1 | 2019 | 239 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2019 | 315 | 0.030 |
Why?
| | Homeostasis | 1 | 2017 | 206 | 0.030 |
Why?
| | Tissue Distribution | 2 | 2008 | 175 | 0.030 |
Why?
| | Metabolism | 1 | 2015 | 25 | 0.030 |
Why?
| | Hyperemia | 1 | 2015 | 17 | 0.030 |
Why?
| | Forearm | 1 | 2015 | 29 | 0.030 |
Why?
| | cdc42 GTP-Binding Protein | 1 | 2015 | 11 | 0.030 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2015 | 34 | 0.030 |
Why?
| | Regional Blood Flow | 1 | 2015 | 109 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2015 | 269 | 0.030 |
Why?
| | Random Allocation | 1 | 2015 | 286 | 0.030 |
Why?
| | Cell Death | 1 | 2015 | 169 | 0.030 |
Why?
| | Resistance Training | 1 | 2015 | 102 | 0.030 |
Why?
| | Protein Kinases | 1 | 2015 | 73 | 0.030 |
Why?
| | Actin Cytoskeleton | 1 | 2014 | 22 | 0.030 |
Why?
| | Endothelium, Vascular | 1 | 2015 | 263 | 0.030 |
Why?
| | Models, Biological | 2 | 2008 | 735 | 0.020 |
Why?
| | Comorbidity | 1 | 2014 | 637 | 0.020 |
Why?
| | Eukaryotic Initiation Factors | 1 | 2012 | 5 | 0.020 |
Why?
| | Argonaute Proteins | 1 | 2012 | 12 | 0.020 |
Why?
| | Multigene Family | 1 | 2012 | 49 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2015 | 1045 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2024 | 6694 | 0.020 |
Why?
| | Prevalence | 1 | 2014 | 1016 | 0.020 |
Why?
| | Exercise | 1 | 2015 | 559 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2012 | 375 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2010 | 165 | 0.020 |
Why?
| | Organ Size | 1 | 2010 | 226 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2013 | 1365 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2010 | 189 | 0.020 |
Why?
| | Down-Regulation | 1 | 2011 | 348 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2013 | 1013 | 0.020 |
Why?
| | NAD | 1 | 2008 | 46 | 0.020 |
Why?
| | Protein Subunits | 1 | 2008 | 79 | 0.020 |
Why?
| | Serum Response Element | 1 | 2007 | 4 | 0.020 |
Why?
| | Codon, Nonsense | 1 | 2007 | 28 | 0.020 |
Why?
| | HeLa Cells | 1 | 2008 | 243 | 0.020 |
Why?
| | Models, Genetic | 1 | 2007 | 173 | 0.020 |
Why?
| | Myocytes, Cardiac | 1 | 2008 | 146 | 0.020 |
Why?
| | Zinc Fingers | 1 | 2006 | 25 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2006 | 121 | 0.020 |
Why?
| | Organ Specificity | 1 | 2006 | 116 | 0.020 |
Why?
| | Binding Sites | 1 | 2006 | 379 | 0.010 |
Why?
| | Two-Hybrid System Techniques | 1 | 2004 | 28 | 0.010 |
Why?
| | Atrial Natriuretic Factor | 1 | 2004 | 21 | 0.010 |
Why?
| | Blotting, Northern | 1 | 2004 | 107 | 0.010 |
Why?
| | Immunoprecipitation | 1 | 2004 | 59 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2004 | 129 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2004 | 140 | 0.010 |
Why?
| | Transcriptional Activation | 1 | 2004 | 127 | 0.010 |
Why?
| | Plasmids | 1 | 2004 | 162 | 0.010 |
Why?
| | Homeodomain Proteins | 1 | 2004 | 80 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2004 | 140 | 0.010 |
Why?
| | Adolescent | 1 | 2015 | 6713 | 0.010 |
Why?
| | Glutathione Transferase | 1 | 2004 | 174 | 0.010 |
Why?
| | Cardiomyopathies | 1 | 2004 | 117 | 0.010 |
Why?
| | Echocardiography, Doppler | 1 | 2003 | 56 | 0.010 |
Why?
| | Models, Animal | 1 | 2003 | 230 | 0.010 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2003 | 107 | 0.010 |
Why?
| | Gene Expression | 1 | 2003 | 618 | 0.010 |
Why?
|
|
Azhar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|